Researchers develop an AI tool to predict cardiometabolic multimorbidity risk in type 2 diabetes, aiding early intervention and personalised care. Find out more.

AI models that can learn as they go are one of the hot new areas drawing interest from both startups and the leading labs, ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a look at where Recursion Pharmaceuticals (NASDAQ:RXRX) stands against the ...

Every synthetic dataset generated today trains tomorrow's models while potentially poisoning the ecosystem those models ...